Advertisement

Topics

Salix Pharmaceuticals Company Profile

04:16 EST 22nd November 2017 | BioPortfolio

Salix Pharmaceuticals is dedicated to being the leading specialty pharmaceutical company providing products to gastroenterologists and their patients. In-license selective late-stage/marketed products Our "search and development" efforts are designed to identify and acquire late-stage and/or marketed proprietary pharmaceutical products for the treatment of gastrointestinal disease that have an existing base of safety and efficacy data. This focus on late-stage products serves to reduce the risk, time and expense Salix invests in products compared to the investment typically associated with the research and early development phases of pharmaceutical products.

Location

1700 Perimeter Park Drive
Morrisville
NC
27560-8404
United States of America

Contact

Phone: 919-862-1000
Fax: 919-862-1095


News Articles [458 Associated News Articles listed on BioPortfolio]

Salix Pharmaceuticals (SLXP) vs. Its Rivals Head to Head Survey

Salix Pharmaceuticals is one of 19 public companies in the "Specialty & Advanced Pharmaceuticals" industry, but how does it contrast to its rivals? We will compare Salix Pharmaceuticals to related...

Salix Pharmaceuticals, Ltd. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 14062017] Prices from USD $350

Salix Pharmaceuticals, Ltd. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Salix Pharmaceuticals, Ltd. Mergers Acquisitions MA, Partnerships Alliances an...

Salix Announces Four Poster Presentations, Two Product Theatres At PAINWeek 2017

BRIDGEWATER, N.J., Sept. 5, 2017 /PRNewswire/ -- Salix Pharmaceuticals today announced it will be presenting data from four abstracts at this year's PAINWeek, the largest national conference on pain f...

EUROPE CHRONIC IDIOPATHIC CONSTIPATION DRUG MARKET FORECAST 20172025 [Report Updated: 19072017] Prices from USD $1250

KEY FINDINGSThe Europe chronic idiopathic constipation drug market is estimated to grow at a CAGR of 6.08% during the forecast years of 20172025.The market value is estimated to increase from $434.7 m...

EUROPE CHRONIC IDIOPATHIC CONSTIPATION DRUG MARKET FORECAST 20172025 [Report Updated: 01011970] Prices from USD $1250

KEY FINDINGSThe Europe chronic idiopathic constipation drug market is estimated to grow at a CAGR of 8.80% during the forecast years of 20172025.The market value is estimated to increase from $1283 mi...

Valeant: Uceris Patent Loss Could Further Impair Salix

Valeant: Salix Growth Might Start To Replace Asset Sales In 2018

NORTH AMERICA CHRONIC IDIOPATHIC CONSTIPATION DRUG MARKET FORECAST 20172025 [Report Updated: 19072017] Prices from USD $1250

KEY FINDINGSThe North America Chronic Idiopathic Constipation Drug Market is expected to grow at a CAGR of 7.20%. The market value is expected to rise from $818 million in 2016 to $1527.50 million by ...

PubMed Articles [133 Associated PubMed Articles listed on BioPortfolio]

Chemical composition and pharmacological potential of aromatic water from Salix caprea inflorescence.

To evaluate the chemical composition and pharmacological potential of hydro distillate from Salix caprea inflorescence.

Investigation of the flavan-3-ol patterns in willow species during one growing-season.

Flavonoids, proanthocyanidins (PAs) and salicylic alcohol derivatives are the main groups of ingredients in Salix needed as defensive tools and signal molecules, but have also pharmaceutical importanc...

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Copper and nickel co-treatment alters metal uptake and stress parameters of Salix purpurea×viminalis.

Simultaneous treatment of Salix purpurea×viminalis with copper (Cu(2+)) and nickel (Ni(2+)) altered metal phytoextraction rates in favor of leaves. Still, metal translocation patters remained unaffec...

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Clinical Trials [211 Associated Clinical Trials listed on BioPortfolio]

Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety

Phase III, multicentric, double blind, randomized study, controlled by Valeriana officinalis for evaluating the efficacy of association of Passiflora incarnata L; Crataegus Oxyacantha L an...

Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety

To evaluate the efficacy and tolerability of the combination use of Passiflora incarnata L, Crataegus oxyacantha and Salix alba L in mild and moderate anxiety. Clinical study phase III, m...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1289 Associated Companies listed on BioPortfolio]

Salix Pharmaceuticals, Ltd. Salix Pharmaceuticals, Ltd.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, NC, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix’s s...

Salix Pharmaceuticals, Inc.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, NC, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix’s s...

Salix Pharmaceuticals

Salix Pharmaceuticals is dedicated to being the leading specialty pharmaceutical company providing products to gastroenterologists and their patients. In-license selective late-stage/marketed produ...

Salix Pharmaceuticals , Ltd.

Salix Pharmaceuticals Ltd.

More Information about "Salix Pharmaceuticals" on BioPortfolio

We have published hundreds of Salix Pharmaceuticals news stories on BioPortfolio along with dozens of Salix Pharmaceuticals Clinical Trials and PubMed Articles about Salix Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Salix Pharmaceuticals Companies in our database. You can also find out about relevant Salix Pharmaceuticals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record